Clinical Trial Update: Plasma N-terminal proBNP Concentrations and Patent Ductus Arteriosus in Preterm Babies

View source ↗

Summary

A completed clinical trial analyzed plasma N-terminal proBNP concentrations in preterm infants to investigate its relationship with patent ductus arteriosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus

Snippet

Sponsor: St George's, University of London | Conditions: Ductus Arteriosus, Patent | Status: COMPLETED